Clinical Trials Directory

Trials / Completed

CompletedNCT04769115

A Predictive Technology for Prevention of Diabetic Foot Ulcers

A Predictive Technology for Prevention of Diabetic Foot Ulcers, and in Real Time, Identifying Diabetic Patients Who Experience Lower Extremity Trauma and Vascular Obstruction Utilizing the Science of Temperature (Inflammation) Trending

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
DAPS Health LLC · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Not accepted

Summary

The DAPSHealth system employs a predictive technology for prevention of diabetic foot ulcers, and in Real Time, identifies diabetic patients who experience lower extremity trauma and vascular obstruction utilizing the science of temperature trending.

Detailed description

Diabetes has become a major health issue in the United States and globally, particularly among older populations. There are currently 400 million diabetics worldwide, with 30 million diagnosed diabetics living in the US. The standard of care today in treating complications of diabetes is a reactive one: doctors often wait for a problem to occur and then treat it. This waiting approach results in high medical expenses and an increase in pain for patients. This study is testing a predictive technology system (investigational bluetooth-enabled thermometer and mobile app) to see if it can identify potential foot complications before the damage becomes irreversible. The thermometer being used in this study is the Exergen DermaTemp (DT) Thermometer. Participants will check the temperature of each foot daily for a period of three months. These results will sync directly from the thermometer to the mobile app. Patients are notified when temperature levels indicate a potential complication that may lead to a developing foot ulcer. The study doctor is available to determine if any trauma or vascular obstruction has occurred and will follow up with the participant.

Conditions

Interventions

TypeNameDescription
DEVICEAlert for temperature deltaIf alert for potential complications refer to appropriate specialist

Timeline

Start date
2021-02-24
Primary completion
2021-07-01
Completion
2021-07-01
First posted
2021-02-24
Last updated
2021-08-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04769115. Inclusion in this directory is not an endorsement.